Creapharm group has acquired a majority stake in the LinBox group, a French private biobank specializing in cryopreservation.

The market for innovative therapeutics is burgeoning. The highly secure preservation and storage of these products, as well as its logistics, is now a real challenge for pharmaceutical laboratories, biotechnology companies and research centres.

By choosing to cooperate with a leader in biobanking Linbox -, an experienced player with complementary know-how -, Creapharm created around Creapharm Bioservices a new business unit aimed at being the first private biobank offering cryogenic preservation of organic products stored for therapeutic purposes.

The Creapharm group was advised by Dentons Paris teams, led by Jean-Marc Grosperrin, M&A partner, Romain Picard and Coralie Leger, associates. Teams of Corporate Department (Thierry Renaud de la Faverie, partner), Labor Law Department (Katell Déniel-Allioux, partner and Nathaly Blin, of Counsel), Data Privacy Department (Christophe Fichet, partner, and Maxime d’Angelo Petrucci, associate), Real Estate Department (Maxime Simonnet, partner and Charlotte Rossi, associate) have also been involved.

The LinBox group and its founding partners (Frédéric Malboze, Marine Thiebaud and Ludivine Miossec) were advised by Étienne Épron and Cassandra Gimbert.